Mirati Therapeutics (MRTX) executive Sandler received 17,021 shares
Insider transactions reported
Alan B. Sandler (Chief Medical Officer at Mirati Therapeutics Inc., MRTX) reported that they received 17,021 shares on Dec 29, 2023. After these transactions the filing shows 79,318 shares held directly.
- Reporting person
- Sandler Alan B.
- Role
- Chief Medical Officer
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Dec 29, 2023 | Grant or award (A) | Common Stock1 | +17,021 | $58.75 | $1,000K | 79,318 direct |
Holdings before and after
- Common Stock: 62,297 to 79,318 direct
Footnotes from the filing
- 1. Grant of Restricted Stock Units (RSUs). Shares will vest 25% annually on the anniversary of the grant date until fully vested.
Transaction codes in this filing
- Grant or award:
- Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
FAQ
What did Sandler report in this MRTX Form 4?
Alan B. Sandler (Chief Medical Officer at Mirati Therapeutics Inc., MRTX) reported that they received 17,021 shares on Dec 29, 2023. After these transactions the filing shows 79,318 shares held directly.
How many MRTX shares does Sandler hold after this filing?
The filing shows 79,318 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code A mean on an SEC Form 4?
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
Historical context for MRTX
Earlier insider filings at MRTX
- Jan 3, 2024Ondrey Aaron was granted 17,021 shares, increasing direct ownership by 76% to 39,461 units (SEC Form 4)
- Jan 3, 2024Baum Charles M was granted 20,425 shares, increasing direct ownership by 9% to 247,700 units (SEC Form 4)
- Dec 19, 2023Christensen Jamie sold $137,252 worth of shares (2,387 units at $57.50), decreasing direct ownership by 2% to 141,645 units (SEC Form 4)
- Dec 14, 2023Hickey Benjamin sold $125,807 worth of shares (2,220 units at $56.67), decreasing direct ownership by 2% to 103,694 units (SEC Form 4)
- Sep 12, 2023SEC Form 4: Christensen Jamie sold $85,084 worth of shares (2,388 units at $35.63), decreasing direct ownership by 2% to 144,032 units
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
Follow MRTX and get a push notification the moment its next story breaks.